NAS:DXCM (USA) Also Trade In: Brazil Germany Mexico UK

DexCom Inc $ 348.03 3.4 (0.99%)

Avg Vol (1m):
Market Cap $:
33.42 Bil
Enterprise Value $:
32.64 Bil
P/E (TTM):
Warning! GuruFocus has detected 3 Severe warning signs with DXCM. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

DXCM News and Headlines - DexCom Inc

GuruFocus Articles Total 27
  • 1
  • 2

Nasdaq up 23.43% for the year

The Dow Jones Industrial Average closed at 27,682.81 on Friday with a loss of 134.09 points or -0.48%. The S&P 500 closed at 3,348.44 for a loss of 32.36 points or -0.96%. The Nasdaq Composite closed at 11,075.02 for a loss of 251.49 points or -2.22%. The VIX Volatility Index was higher at 27.63 for a gain of 0.93 points or 3.48%.

For the week, the Dow Jones gained 1.9%, the S&P 500 gained 1.5% and the Nasdaq gained 1.4%. For the year, the Nasdaq has a gain of 23.43%, the S&P 500 is up 3.64% and the Dow Jones

52 Views    Julie Young    2020-10-03 19:41
Sands Capital Management invests in communications and health care in 2nd quarter

Sands Capital Management recently disclosed its portfolio updates for the second quarter of 2020, which ended on June 30.

Founded in 1992 by Frank M. Sands Sr., Sands Capital Management is a staff-owned independent investment management firm that invests in high-quality growth business. Frank Sands (Trades, Portfolio) Jr. joined the firm in 2000 and now serves as CEO and chief investment officer. The Arlington, Virginia-based firm has two main concentrated growth strategies: Select Growth, which chooses innovative businesses, and Global Growth, which diversifies holdings in countries outside of the U.S. Sands Capital Management has achieved success by

295 Views    Margaret Moran    2020-08-13 21:22
Stocks with the highest year-to-date return as Nasdaq closes above 10,000 for the first time ever

The Nasdaq Composite Index closed on Wednesday above 10,000 for the first time in history as investors continue their optimistic bet on the economy recovering from the coronavirus-related shutdown. Among the S&P 500 companies trading on the Nasdaq exchange, the five stocks with the largest year-to-date total return are DexCom Inc. (DXCM), Regeneron Pharmaceuticals Inc. (REGN), Nvidia Corp. (NVDA), PayPal Holdings Inc. (PYPL) and Abiomed Inc. (ABMD).

Tech-heavy Nasdaq reaches five-digit intraday high, boosted by Apple and Amazon

The Nasdaq Composite closed at 10,020.35, up 66.59 points from Tuesday’s close of 9,953.75. Inc. (AMZN), a major

624 Views    James Li    2020-06-10 21:59
Guru releases portfolio for the 1st quarter

Guru Frank Sands (Trades, Portfolio), CEO and chief investment officer of Sands Capital Management, released his first-quarter portfolio earlier this month, listing five new holdings.

The Arlington, Virginia-based value investment firm, which was founded by Sands’ father in 1992, approaches stock picking with the belief that, over time, stock prices reflect the underlying company’s earnings growth. Using a fundamental, business-focused process, the investment team looks for a concentrated number of high-quality, wealth-creating growth opportunities to hold for the long term.

Keeping these criteria in mind, Sands established positions in Uber Technologies Inc. (UBER), Square Inc. (SQ), Zillow

518 Views    Sydnee Gatewood    2020-05-26 16:38
Large allocations to the purchase of fixed assets may anticipate growth

The following companies may be of interest to investors, as they have increased their capital spending over the past five years. This suggests that these companies could expect a higher demand for their products and services.

Furthermore, Wall Street analysts expect that these stocks will increase their earnings per share significantly, beating the S&P 500 this year and over the next one to five years.

DexCom Inc

The first company that meets the above-listed criteria is DexCom Inc (DXCM), a San Diego, California-based medical device company that provides U.S. and international healthcare organizations with glucose monitoring systems.

DexCom allocated

127 Views    Alberto Abaterusso    2020-05-11 14:25
Enphase Energy makes the list

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned stocks have outperformed the S&P 500 Index over the past 12 months as of March 31.

Axsome Therapeutics

Axsome Therapeutics Inc. (AXSM) has a market cap of $2.11 billion. It has outperformed the S&P 500 by 312% over the past year.


Shares are trading with a price-book ratio of 11.08. As of Tuesday, the share price was 659% above the 52-week low and 47.22% below the 52-week high.

The health care service provider has a profitability rating of 1 out of

189 Views    Tiziano Frateschi    2020-03-31 19:52
Deals further strengthen company's position in large and growing market for continuous glucose monitoring

Insulet Corp. (PODD) hit its 52-week high on Feb. 19 after announcing formation of two partnerships that further strengthens its leading role in the market for continuous glucose monitoring.

Trading at just over $211 and with a market cap of more than $13 billion, the Acton, Massachusetts-based company may now be too pricey for both investors and potential acquirers. The company is on the list of the 25 most attractive public acquisition targets in medtech, according to an article in Medical Device and Diagnostic Industry that was updated in mid-2019.

Individual investors have to factor in the latest

93 Views    Barry Cohen    2020-02-21 21:36
Firm releases its 4th-quarter portfolio

Lone Pine Capital, the hedge fund founded by Steve Mandel (Trades, Portfolio), disclosed 12 new holdings when it released its fourth-quarter 2019 portfolio last week.

The Greenwich, Connecticut-based firm picks stocks using a long-short strategy that focuses on bottom-up, fundamental analysis. Combining growth and value strategies, the firm, whose founder was a former “tiger cub” of Julian Robertson (Trades, Portfolio), is known to not hold positions for very long.

Taking these criteria into consideration, Lone Pine’s top five new buys for the quarter were PayPal Holdings Inc. (PYPL), Match Group Inc. (MTCH), Luckin Coffee

840 Views    Sydnee Gatewood    2020-02-19 19:03
Guru ends the year with a position in newly public Peloton

Spiros Segalas (Trades, Portfolio), manager of the Harbor Capital Appreciation Fund, disclosed four new positions when he released his fourth-quarter 2019 portfolio earlier this week.

Part of Chicago-based Harbor Funds, the guru’s fund primarily invests in companies with market caps of at least $1 billion at the time of purchase. He focuses on companies that have strong balance sheets and earnings performance, good sales momentum and growth outlook, a history of high profitability, a unique market position and a capable, committed management team.

Based on these criteria, Segalas established holdings in Shopify Inc. (SHOP), Dexcom Inc. (DXCM),

344 Views    Sydnee Gatewood    2020-01-08 17:00
These five companies have recently managed to achieve 52-week highs

According to the GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.

Ingersoll-Rand PLC reached the 52-week high of $130.44

Ingersoll-Rand PLC (IR)Â is a diversified industrial company that operates in two segments. The $10.5 billion climate segment manufactures and services HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard and Thermo King brands. The $3 billion industrial segment sells Ingersoll-Rand-branded compression systems and power tools, ARO-branded fluid management equipment and Club Car-branded utility vehicles. The company generates about 65% of its sales in the United States.

38 Views    yifan900    2019-11-14 15:38
Amgen, DexCom among those companies

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Seven gurus are invested in Amgen Inc. (AMGN).

The company discovers, develops and commercializes therapies to treat cancer. It has a market cap of $117.02 billion. Its revenue has grown 10.40% annually over the past 10 years.

The stock is trading with a price-earnings (P/E) ratio of 66.08. The current price of $172.93 is 12.98% below its 52-week high and 15.08% above its 52-week low. Over the past 10 years, it has returned a gain of 311%.

The company’s largest shareholder among the

69 Views    Tiziano Frateschi    2018-04-23 14:38
The fund favored two industries within the sector

The Vanguard Health Care Fund (Trades, Portfolio), managed my Jean Hynes, bought six new positions in the third quarter, it revealed Monday.

The new positions represented two industries equally: biotech, and medical diagnostics and research. The three from biotech were: bluebeard bio Inc. (BLUE), BeiGene Ltd. (BGNE) and Galapagos NV (XAMS:GLPG). Medical instruments and diagnostics companies were: Essilor International SA (XPAR:EI), DexCom Inc. (DXCM) and PRA Health Sciences Inc. (PRAH).

The portfolio of the Vanguard Health Care Fund (Trades, Portfolio) had 80 positions as of the end of the third quarter. Together, they had

965 Views    Holly LaFon    2017-10-30 21:45
The company has a disruptive product in the diabetes monitoring industry that could be vastly profitable

(This article was originally featured on CNA Finance)

Disclosure: I hold no position in any stock mentioned herein and have no plans to open any position within the next 72 hours.

201 Views    Joshua Rodriguez    2017-06-07 20:09
Stocks with negative 6-month performances

While gurus hold positions in these companies, the stock price and returns continue to fall. These are the worst-performing stocks over the last three months with a long-term presence in more than four gurus’ portfolios.

Acuity Brands Inc. (AYI) had a negative performance of 25.9% over the last six months. Three mutual funds hold the stock with a total weight of 0.06% on their portfolios.

The company has a market cap of $7.83 billion, and the stock is trading with a price-sales (P/S) ratio of 2.27. The price of $177.68 is 36.74% below its 52-week high and 4.81% above

178 Views    Tiziano Frateschi    2017-04-14 21:08
Insiders sell holdings in Fidelity National Financial, DexCom and Facebook

According to GuruFocus Insider Data, the recent CFO sells were: Fidelity National Financial Inc. (FNF), DexCom Inc. (DXCM) and Facebook Inc. (FB).

Fidelity National Financial: EVP and CFO Anthony Park sold 34,542 shares

EVP and CFO Anthony Park sold 34,542 shares at a price of $35.66 on June 9. The price of the stock has decreased by 2.78%. Fidelity National Financial has a market cap of $11.88 billion, and its shares were traded around $34.67. The company has a P/E ratio of 18.44 and P/S ratio of 1.08. The trailing 12-month dividend yield and forward dividend yield of Fidelity National

2576 Views    Myra Ramdenbourg    2016-06-28 19:23
Guru stock highlight

Another health care holding, DexCom, Inc., (NASDAQ:DXCM) sells a continuous glucose monitoring system for diabetics. Although this is an unusual investment for the portfolio because of its extended trading multiple, we think DexCom’s fundamentals justify our investment. Over the last three years, DexCom has launched a series of new products driving a dramatic acceleration in revenue growth. We believe the company’s new product pipeline remains robust and will lead to further adoption among the growing population of diabetics.

From the Baron Funds Small Cap Fund winter newsletter 2016.

490 Views    Holly LaFon    2016-01-14 17:04
By Baron Small Cap Fund Portfolio Manager Cliff Greenberg

Compared to large-cap stocks, the landscape of small-cap stocks is broader, less well-known, and more volatile. While these aspects of the small-cap space may cause some investors to steer clear, it has its distinct advantages. Historically, small caps have outperformed large caps while providing investors with diversification. We also believe that, given current market conditions, now may be an opportune time in which to invest in small cap stocks. This equity asset class tends to outperform large caps in a rising interest rate environment. In addition, small-caps are typically less exposed to foreign exchange headwinds generated by a strong dollar

862 Views    Holly LaFon    2016-01-14 16:40
DexCom, Gilead Sciences, Palo Alto Networks, lead the way

According to GuruFocus Insider Data, the largest insider sells during the past week were DexCom Inc. (DXCM), Gilead Sciences Inc. (GILD), Palo Alto Networks Inc. (PANW) and Inc. (CRM).

The overall trend of insiders is illustrated in the chart below:

DexCom Inc.: Executive Chairman Terrance H. Gregg sold 160,001 shares

DexCom Executive Chairman Terrance H. Gregg sold 160,001 shares during the past week at an average price of $95.73 per share.

DexCom designs, develops and commercializes glucose monitoring systems for ambulatory use by people with diabetes. The company has a market cap

663 Views    Jimmy Xiao    2015-09-15 15:31
Gilead CFO sells 6,250 shares of the company

According to GuruFocus Insider Data, the recent CFO sales were: Gilead Sciences Inc. (GILD), DexCom Inc. (DXCM), and Palo Alto Networks Inc. (PANW).

Gilead Sciences Inc.: EVP, CFO Robin L Washington sold 6,250 shares

On Sept. 2, EVP and CFO Robin L Washington sold 6,250 shares at an average price of $102.2. The price of the stock has increased by 7.27%. Gilead Sciences Inc. has a market cap of $160.89 billion and its shares were traded at around $109.63.The company has a P/E ratio of 11.49 and P/S ratio of 5.97 with a dividend yield of 0.39%. Over the past

1385 Views    Myra Ramdenbourg    2015-09-13 19:16

Stopping by my local Starbucks on Tuesday, this was on the front page of the Star-Ledger:

Don't Panic

A couple of embarrassingly Jersey items on the left, but in the middle is the typical advice offered to unhedged, long-only investors when the crap hits the fan. A better approach, I think, is for investors to be positioned in such away that they'll have no reason to panic, because their downside is strictly limited. That's the point of the hedged portfolio method.

Stocks for small hedged portfolio weather Tuesday's session

In a post

394 Views    David Pinsen    2015-08-26 16:16

Headlines Total 218
  • 1
  • 2
  • 3

2020-12-03 $ 344.63 (3.43%)
2020-11-30 $ 319.68 (0.46%)
2020-11-27 $ 318.21 (1.81%)
2020-11-19 $ 330.64 (0.43%)
2020-11-18 $ 329.21 (-1.54%)
2020-11-17 $ 334.35 (-1.67%)
2020-11-10 $ 339.53 (-1.25%)
2020-10-30 $ 319.58 (-4.69%)
2020-10-28 $ 349.12 (-8.28%)
2020-10-27 $ 380.63 (-8.94%)
2020-10-21 $ 387.84 (-1.17%)
2020-10-20 $ 392.43 (-1.28%)
2020-10-14 $ 394.01 (-1.73%)
2020-10-13 $ 400.94 (1.71%)
2020-10-08 $ 387.5 (-1.6%)
2020-10-02 $ 384.52 (-7.08%)
2020-10-01 $ 413.84 (0.39%)
2020-09-28 $ 400.19 (-0.54%)
2020-09-24 $ 382.03 (-1.05%)
2020-09-22 $ 398.13 (1.64%)
2020-09-21 $ 391.69 (0.61%)
2020-09-18 $ 389.31 (0.8%)
2020-09-17 $ 386.21 (-1.96%)
2020-09-11 $ 383.46 (-1.68%)
2020-09-10 $ 390.02 (-2.9%)
2020-09-04 $ 398.24 (-3.56%)
2020-09-02 $ 447.71 (6.04%)
2020-08-27 $ 427.75 (0.48%)
2020-08-20 $ 431.88 (-0.23%)
2020-08-13 $ 435.28 (1.73%)
2020-08-11 $ 411.15 (-2.39%)
2020-08-07 $ 440.7 (0.39%)
2020-08-03 $ 443.67 (1.87%)
2020-07-29 $ 427.08 (2.22%)
2020-07-28 $ 417.79 (-1.33%)
2020-07-27 $ 423.43 (0.4%)
2020-07-24 $ 421.75 (0.41%)
2020-07-23 $ 420.01 (-1.44%)
2020-07-22 $ 426.15 (-0.67%)
2020-07-21 $ 429.02 (-0.77%)
2020-07-20 $ 432.37 (1.87%)
2020-07-16 $ 413.22 (-1.13%)
Is Dexcom Stock a Buy? -
2020-07-13 $ 404.23 (-8.05%)
2020-07-10 $ 439.64 (-0.2%)
2020-07-08 $ 435.11 (2.17%)
2020-07-06 $ 423.18 (3.89%)
2020-07-01 $ 400.21 (-1.28%)
2020-06-30 $ 405.4 (1.81%)
2020-06-26 $ 383.06 (-3.78%)
2020-06-25 $ 398.09 (0.96%)
2020-06-19 $ 409.36 (1.85%)
2020-06-18 $ 401.91 (-0.31%)
2020-06-17 $ 403.18 (2.59%)
2020-06-16 $ 393 (-1.44%)
2020-06-15 $ 398.75 (7.7%)
2020-06-12 $ 370.23 (2.07%)
2020-06-10 $ 385.17 (1.23%)
2020-06-09 $ 380.5 (3.22%)
2020-06-08 $ 368.62 (1.13%)
2020-06-05 $ 364.49 (5.7%)
2020-06-04 $ 344.85 (-5.74%)
2020-06-03 $ 365.86 (-2.63%)
2020-06-02 $ 375.75 (-0.78%)
Total 218
  • 1
  • 2
  • 3